Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation TechnologyGlobeNewsWire · 5 days ago
Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026GlobeNewsWire · Oct 5, 2026
Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire · Sep 15, 2026
Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation TechnologyGlobeNewsWire · Sep 14, 2026
Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026GlobeNewsWire · Sep 3, 2026
Baird Medical Investment (NASDAQ:BDMD) Trading Down 2.5% – Should You Sell?Defense World · Aug 21, 2026Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.